CHA University
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1999-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.cha.ac.kr
The Rule-Out Acute Myocardial Infarction Using Aritifical Intelligence Electrocardiogram (ROMIAE) 2 Trial
Not Applicable
Not yet recruiting
- Conditions
- Myocardial Infarction (MI)Chest Pain Rule Out Myocardial Infarction
- First Posted Date
- 2025-06-19
- Last Posted Date
- 2025-06-19
- Lead Sponsor
- CHA University
- Target Recruit Count
- 4670
- Registration Number
- NCT07027891
Medipixel XA-Assisted PCI in Coronary Artery Disease
Not Applicable
Recruiting
- Conditions
- Percutaneous Coronary Intervention (PCI)Coronary Arterial Disease (CAD)
- First Posted Date
- 2025-05-22
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- CHA University
- Target Recruit Count
- 830
- Registration Number
- NCT06985693
- Locations
- 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of
🇰🇷Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Gyeonggi, Korea, Republic of
🇰🇷Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of
Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer (GemCiNT)
Recruiting
- Conditions
- Locally Advanced Biliary Tract CancersMetastatic Biliary Tract Cancers
- Interventions
- Drug: Gemcitabine, Cisplatin, Nab-paclitaxel, and Tislelizumab.
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- CHA University
- Target Recruit Count
- 61
- Registration Number
- NCT06893380
- Locations
- 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of
The Analysis of Efficacy Factors for Autologous Platelet-Rich Plasma Therapy in the Treatment of Elbow Tendinopathy
Phase 4
Not yet recruiting
- Conditions
- Elbow Tendinopathy
- Interventions
- Biological: Autologous Platelet-Rich Plasma (PRP) Injection
- First Posted Date
- 2025-02-07
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- CHA University
- Target Recruit Count
- 30
- Registration Number
- NCT06815042
- Locations
- 🇰🇷
Bundang CHA Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
Recruiting
- Conditions
- Biliary Tract CancerCholangiocarcinoma
- Interventions
- First Posted Date
- 2024-10-18
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- CHA University
- Target Recruit Count
- 100
- Registration Number
- NCT06648057
- Locations
- 🇰🇷
Bundang CHA Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of
RCVR (Residual CardioVascular Risk) Prospective Multicenter Study
Recruiting
- Conditions
- Coronary Artery Disease
- Interventions
- Diagnostic Test: Blood SampleOther: DICOM Dataset
- First Posted Date
- 2024-09-30
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- CHA University
- Target Recruit Count
- 1000
- Registration Number
- NCT06619353
- Locations
- 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of
MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study
- First Posted Date
- 2024-08-07
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- CHA University
- Target Recruit Count
- 490
- Registration Number
- NCT06543082
- Locations
- 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of
Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive
Phase 4
Completed
- Conditions
- GlaucomaOcular Hypertensive
- Interventions
- Drug: BRIDIN-plus Eye drops
- First Posted Date
- 2023-10-12
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- CHA University
- Target Recruit Count
- 60
- Registration Number
- NCT06078592
- Locations
- 🇰🇷
Seungsoo Rho, Seoul, Seongnam, Bundang-gu, Korea, Republic of
Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma Patients
Not Applicable
Recruiting
- Conditions
- Glaucoma
- Interventions
- Other: Nicotinamide(Mitovita)Other: Placebo
- First Posted Date
- 2023-10-12
- Last Posted Date
- 2023-10-12
- Lead Sponsor
- CHA University
- Target Recruit Count
- 80
- Registration Number
- NCT06078605
- Locations
- 🇰🇷
CHA University Bundang Medical Center, Seongnam, Bundang-gu, Korea, Republic of
Development of the Neuroimaging Biomarker-based Prediction Model of Anxiety-related Disorders: Effect of Mindfulness-based Cognitive Therapy Using Neuroscience on the Brain
Not Applicable
Not yet recruiting
- Conditions
- Anxiety Depression
- Interventions
- Behavioral: Mindfulness-based cognitive therapy using neuroscience (NMBCT)
- First Posted Date
- 2023-06-22
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- CHA University
- Target Recruit Count
- 64
- Registration Number
- NCT05911412